2 chapters across the catalog
Reports from patients indicate high costs for coronavirus-related doctor visits, with some receiving $500 bills for simple temperature checks. While insurance companies have pledged to cover copays for COVID-19 treatment, concerns remain regarding future premium increases.
Pharma Lobbying, Restless Leg Syndrome, Insurance Copay Scams
A pharmaceutical lobbyist defends direct-to-consumer advertising as a tool for "raising awareness" for conditions like depression and restless leg syndrome. The hosts argue that these ads are designed to drive patients to doctors to request specific high-cost drugs, noting that insurance copays are often calculated based on inflated retail prices that insurers never actually pay.
